Welcome to our dedicated page for DT Cloud Acqsn news (Ticker: DYCQR), a resource for investors and traders seeking the latest updates and insights on DT Cloud Acqsn stock.
DT Cloud Acqsn (DYCQR) News Hub provides centralized access to official corporate announcements and market-moving developments for this cloud technology innovator. Track all material updates including earnings disclosures, strategic partnerships, and product launches related to enterprise cloud solutions.
This resource serves investors requiring timely insights into DYCQR's operational milestones and analysts monitoring cloud computing sector dynamics. Discover press releases detailing infrastructure expansions, IT service innovations, and acquisition activity shaping the company's market position.
Content spans financial reports, leadership updates, technology deployments, and industry event participation. Regular updates ensure stakeholders stay informed about developments impacting digital transformation services and managed IT solutions.
Bookmark this page for streamlined access to verified DYCQR communications, with new content added as corporate announcements are released through official channels.
DT Cloud Acquisition (Nasdaq: DYCQU) has announced changes to its upcoming Extraordinary General Meeting (EGM) schedule. The meeting, originally planned for April 18, 2025, at 10:00 a.m. Eastern Time, has been rescheduled to April 23, 2025, at the same time.
Key updates include:
- New redemption right deadline: April 21, 2025, at 5:00 p.m. Eastern Time
- Record date remains unchanged: March 31, 2025
- No modifications to shareholder voting proposals
The SPAC has filed a definitive proxy statement with the SEC on April 3, 2025, followed by additional proxy supplements on April 3, 4, and 9, 2025. Previously submitted proxy votes remain valid unless shareholders wish to change their vote. All relevant documents are available through the SEC website.
DT Cloud Acquisition (Nasdaq: DYCQU, DYCQ, DYCQR) has announced the cancellation of its extraordinary general meeting (EGM) that was scheduled for February 21, 2025, at 10:00 a.m. Eastern Time. The SPAC has also withdrawn all proposals that were outlined in its definitive proxy statement filed with the SEC on January 27, 2025, including its subsequent amendments from February 4, 14, and 19, 2025.
DT Cloud Acquisition (Nasdaq: DYCQU) has announced changes to its upcoming Extraordinary General Meeting (EGM) schedule. The meeting, originally set for February 18, 2025, has been rescheduled to February 21, 2025 at 10:00 a.m. Eastern Time. Additionally, the redemption right deadline has been moved to February 19, 2025, at 5:00 p.m. Eastern Time.
The SPAC has filed a proxy supplement on February 14, 2025, with an amendment on February 19, 2025, proposing an increase in the monthly extension fee to $0.022 per outstanding Public Share under Proposal 1 of the EGM.
DT Cloud Acquisition (Nasdaq: DYCQU) has announced a business combination agreement with Maius Pharmaceutical, a biopharmaceutical R&D company. The transaction values Maius at $250 million in equity value. Upon closing, Maius will become a wholly-owned subsidiary of Maius Pharmaceutical Group, with securities listed on Nasdaq. Maius focuses on developing innovative formulations and targeted small-molecule chemical drugs in three areas: anticancer drugs, autoimmune medication, and anti-infectives. The transaction is expected to close in the first half of 2025, subject to regulatory and shareholder approvals.
DT Cloud Acquisition (Nasdaq: DYCQU, DYCQ, DYCQR) has announced a non-binding letter of intent (LOI) for a business combination with Shanghai Maius Pharmaceutical Technology Co., Founded in 2015, Shanghai Maius is a biopharmaceutical R&D company specializing in innovative formulations and targeted small-molecule chemical drugs.
The proposed deal would involve DT Cloud acquiring 100% of Shanghai Maius's equity or all of its business, with the final structure to be determined. The combined public company would adopt Shanghai Maius's branding. A definitive agreement is expected in Q4 2024, subject to board and shareholder approvals, regulatory clearances, and other conditions.